Prevalence of cytomegalovirus infection and its role in total immunoglobulin pattern in Iranian patients with different subtypes of multiple sclerosis

• Published in: The New microbiologica Vol. 34; no. 3; pp. 263 - 274
• Main Authors: Sanadgol, Nima, Ramroodi, Nourollah, Ahmadi, Ghasem Ali, Komijani, Majid, Moghtaderi, Ali, Bouzari, Majid, Rezaei, Marzieh, Kardi, Mohammad Taghi, Dabiri, Soroush, Moradi, Malek, Sanadgol, Ehsan
• Format: Journal Article
• Language: English
• Published: Italy 01.07.2011
• Subjects: Adolescent; Adult; Autoimmune diseases; Central nervous system; Cytomegalovirus; Cytomegalovirus Infections - epidemiology; Cytomegalovirus Infections - immunology; Cytomegalovirus Infections - virology; Demyelination; Disseminated infection; Enzymes; Female; Humans; Immune response; Immunity (humoral); Immunoglobulin E; Immunoglobulin E - immunology; Immunoglobulin G; Immunoglobulin M - immunology; Immunoglobulins - immunology; Inflammation; Male; Middle Aged; Multiple sclerosis; Multiple Sclerosis - epidemiology; Multiple Sclerosis - immunology; Multiple Sclerosis - virology; Peripheral blood mononuclear cells; Polymerase Chain Reaction; Saliva; Urine; Young Adult
• ISSN: 1121-7138

Multiple sclerosis (MS) is the most common autoimmune disease characterized by multifocal areas of inflammatory demyelination within the central nervous system. Cytomegalovirus (CMV) has a complex pathobiology and in most cases is simply asymptomatic. There is some recent controversy over the role of CMV in the pathology of MS. The aim of this study was to evaluate active CMV infection and its effect on the humoral immunity in patients with MS. Serum, plasma, peripheral blood mononuclear cells (PBMCs), saliva and urine collected from MS patients (n=78) and healthy subjects (n=123) were screened for the presence of anti-CMV antibodies and CMV-DNA by nephelometric and PCR methods. Concentrations of total antibodies in MS subtypes were measured using both nephelometric and enzyme linked fluorescent assay (ELFA) techniques. The results extend the observation of an increased frequency of CMV-DNA in patients, in contrast with controls (p<0.001). Furthermore, systemic CMV infections were found in 25.5% of patients and only 3.2% of controls (p<0.001). There was significant difference in the titers of anti-CMV IgG and total IgE in patient and controls (P<0.001). These results support the hypothesis that CMV may contribute to MS thought to establish systemic infection process and induce immune response.